Founder of Vineti, Inc., Heidi M. Hagen is on the board of Vericel Corp., Obsidian Therapeutics, Inc. and A-Alpha Bio, Inc. In the past Ms. Hagen was Independent Director at Alaunos Therapeutics, Inc., Chief Strategy Officer of Vineti, Inc., Global Chief Operating Officer at Sotio Biotech AS, Chief Technical Officer of Sonoma Biotherapeutics, Inc., Senior Vice President-Operations for Dendreon Corp., Chief Operating & Commercial Officer at ZappRx, Inc. and Global Chief Operating Officer at Sotio LLC.

Ms. Hagen received a graduate degree, an undergraduate degree and an MBA from the University of Washington.